Lovenox News
Most Popular Lovenox Story
Apixaban superior to Lovenox in study
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb and Pfizer, was statistically superior to Sanofi-Aventis' Lovenox (enoxaparin) in reducing the incidence of venous Read more...
Latest Headlines
- December 22, 2011
- October 21, 2010
- July 26, 2010
- March 5, 2010
- May 30, 2008
- March 27, 2008
- November 7, 2007
- November 6, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
